Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lone Oak Medical Technologies is a private U.S. medical device company focused on bone mineral density assessment. The company manufactures, distributes, and services the accudxa2 portable peripheral DXA bone densitometer, a device used to estimate bone density from the middle finger and support osteoporosis risk assessment. Its product is positioned as a compact, low-cost alternative to larger central DXA systems and is intended for use in clinics, physician offices, and other point-of-care settings. FDA 510(k) clearance for the ACCUDXA2 was granted in 2012, and the company appears to operate as a commercial-stage device business rather than a therapeutic drug developer. The business is healthcare-related, but it is not a biotech or pharma pipeline company in the usual sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lone Oak Medical Technologies.